119 related articles for article (PubMed ID: 8174413)
1. Cholecystokinin analog, JMV-180, stimulates growth of human pancreatic cancer.
Swift IR; Smith JP
Dig Dis Sci; 1994 May; 39(5):1007-13. PubMed ID: 8174413
[TBL] [Abstract][Full Text] [Related]
2. Both low- and high-affinity CCK receptor states mediate trophic effects on rat pancreatic acinar cells.
Hoshi H; Logsdon CD
Am J Physiol; 1993 Dec; 265(6 Pt 1):G1177-81. PubMed ID: 8279569
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of pancreatic growth by cholecystokinin is mediated by high affinity receptors on rat pancreatic acinar cells.
Dawra R; Saluja A; Lerch MM; Saluja M; Logsdon C; Steer M
Biochem Biophys Res Commun; 1993 Jun; 193(3):814-20. PubMed ID: 8323557
[TBL] [Abstract][Full Text] [Related]
4. Study of the states and populations of the rat pancreatic cholecystokinin receptor using the full peptide antagonist JMV 179.
Silvente Poirot S; Hadjiivanova C; Escrieut C; Dufresne M; Martinez J; Vaysse N; Fourmy D
Eur J Biochem; 1993 Mar; 212(2):529-38. PubMed ID: 8444190
[TBL] [Abstract][Full Text] [Related]
5. High-affinity CCK-A receptors on the vagus nerve mediate CCK-stimulated pancreatic secretion in rats.
Li Y; Hao Y; Owyang C
Am J Physiol; 1997 Sep; 273(3 Pt 1):G679-85. PubMed ID: 9316472
[TBL] [Abstract][Full Text] [Related]
6. Cholecystokinin B-type receptor signaling is involved in human pancreatic cancer cell growth.
Kaufmann R; Schafberg H; Rudroff C; Henklein P; Nowak G
Neuropeptides; 1997 Dec; 31(6):573-83. PubMed ID: 9574824
[TBL] [Abstract][Full Text] [Related]
7. Cholecystokinin-JMV-180 and pilocarpine are potent inhibitors of cholecystokinin and carbachol actions on guinea pig pancreatic acinar cells.
Sjödin L; Viitanen E; Gylfe E
Naunyn Schmiedebergs Arch Pharmacol; 1997 May; 355(5):631-7. PubMed ID: 9151303
[TBL] [Abstract][Full Text] [Related]
8. CCK satiety is differentially mediated by high- and low-affinity CCK receptors in mice and rats.
Weatherford SC; Laughton WB; Salabarria J; Danho W; Tilley JW; Netterville LA; Schwartz GJ; Moran TH
Am J Physiol; 1993 Feb; 264(2 Pt 2):R244-9. PubMed ID: 8447480
[TBL] [Abstract][Full Text] [Related]
9. The cholecystokinin analogues JMV-180 and CCK-8 stimulate phospholipase C through the same binding site of CCK(A) receptor in rat pancreatic acini.
Sarri E; Ramos B; Salido GM; Claro E
Br J Pharmacol; 2001 Aug; 133(8):1227-34. PubMed ID: 11498507
[TBL] [Abstract][Full Text] [Related]
10. CCK-JMV-180: a peptide that distinguishes high-affinity cholecystokinin receptors from low-affinity cholecystokinin receptors.
Stark HA; Sharp CM; Sutliff VE; Martinez J; Jensen RT; Gardner JD
Biochim Biophys Acta; 1989 Feb; 1010(2):145-50. PubMed ID: 2463851
[TBL] [Abstract][Full Text] [Related]
11. Involvement of RhoA and its interaction with protein kinase C and Src in CCK-stimulated pancreatic acini.
Nozu F; Tsunoda Y; Ibitayo AI; Bitar KN; Owyang C
Am J Physiol; 1999 Apr; 276(4):G915-23. PubMed ID: 10198335
[TBL] [Abstract][Full Text] [Related]
12. Cholecystokinin (CCK)-induced desensitization of pancreatic enzyme secretion is mediated by low affinity CCK receptors.
Menozzi D; Stark HA; Martinez J; Jensen RT; Gardner JD
Peptides; 1989; 10(2):337-41. PubMed ID: 2474153
[TBL] [Abstract][Full Text] [Related]
13. Occupation of low-affinity cholecystokinin (CCK) receptors by CCK activates signal transduction and stimulates amylase secretion in pancreatic acinar cells.
Vinayek R; Patto RJ; Menozzi D; Gregory J; Mrozinski JE; Jensen RT; Gardner JD
Biochim Biophys Acta; 1993 Mar; 1176(1-2):183-91. PubMed ID: 7680902
[TBL] [Abstract][Full Text] [Related]
14. Cholecystokinin-induced formation of inositol phosphates in pancreatic acini.
Rowley WH; Sato S; Huang SC; Collado-Escobar DM; Beaven MA; Wang LH; Martinez J; Gardner JD; Jensen RT
Am J Physiol; 1990 Oct; 259(4 Pt 1):G655-65. PubMed ID: 1699431
[TBL] [Abstract][Full Text] [Related]
15. Cholecystokinin receptors and PANC-1 human pancreatic cancer cells.
Smith JP; Rickabaugh CA; McLaughlin PJ; Zagon IS
Am J Physiol; 1993 Jul; 265(1 Pt 1):G149-55. PubMed ID: 8338163
[TBL] [Abstract][Full Text] [Related]
16. Transfected cholecystokinin receptors mediate growth inhibitory effects on human pancreatic cancer cell lines.
Detjen K; Fenrich MC; Logsdon CD
Gastroenterology; 1997 Mar; 112(3):952-9. PubMed ID: 9041258
[TBL] [Abstract][Full Text] [Related]
17. Cholecystokinin inhibits gastric emptying and contracts the pyloric sphincter in rats by interacting with low affinity CCK receptor sites.
Moran TH; Kornbluh R; Moore K; Schwartz GJ
Regul Pept; 1994 Aug; 52(3):165-72. PubMed ID: 7800848
[TBL] [Abstract][Full Text] [Related]
18. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor.
Poirot SS; Escrieut C; Dufresne M; Martinez J; Bouisson M; Vaysse N; Fourmy D
Mol Pharmacol; 1994 Apr; 45(4):599-607. PubMed ID: 8183238
[TBL] [Abstract][Full Text] [Related]
19. Effects of cholecystokinin (CCK) and other secretagogues on isoforms of protein kinase C (PKC) in pancreatic acini.
Pollo DA; Baldassare JJ; Honda T; Henderson PA; Talkad VD; Gardner JD
Biochim Biophys Acta; 1994 Oct; 1224(1):127-38. PubMed ID: 7524684
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the novel CCK analogs JMV-180, JMV-320, and JMV-332 in H345 cells.
Witte DG; Nadzan AM; Martinez J; Rodriguez M; Lin CW
Peptides; 1992; 13(6):1227-32. PubMed ID: 1337381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
